About
Digital biomarkers hold great promise to consistently and objectively quantify a patient’s disease state and response to treatment. Despite this potential, the proprietary nature of many digital biomarker algorithms renders them inaccessible to the scientific community, hindering their validation and improvement.
OpenDBM is an open-source platform that breaks down these barriers and democratizes access to AiCure’s digital biomarker algorithms so researchers can apply them to their own datasets. This transparency encourages industry and academic collaboration, helping to validate digital biomarkers as a legitimate means to understanding disease and patient behavior.
Our team
ADParedes
Admin